170525 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
CD71 BINDING FIBRONECTIN TYPE III DOMAINS
#2Mesothelin-Binding Theranostic Fibronectin Type III Tenth Domain (Fn3) Compounds
#3Assay for Assessing Cancer
#4ASSAYS FOR DETECTION AND QUANTITATION OF HUMAN ENDOTROPHIN
#5MARKERS USEFUL IN ENRICHMENT STRATEGIES FOR THE TREATMENT OF OSTEOARTHRITIS
#6LABEL-FREE IDENTIFICATION OF TUMOR TISSUES BY COHERENT NONLINEAR VIBRATIONAL MODE IMAGING
#7COLLAGEN-RICH ORGANIC COMPOSITION AND PRODUCTION METHOD THEREOF
#8Chronic kidney disease detection
#9COMPOSITION, AQUEOUS SOLUTION OF ENDOCRINE PROTEIN, ADSORPTION INHIBITOR, METHOD FOR SUPPRESSING ADSORPTION OF ENDOCRINE PROTEIN, METHOD FOR MEASURING AMOUNT OF ENDOCRINE PROTEIN, AND REAGENT KIT FOR MEASURING ENDOCRINE PROTEIN
#10Type XIX Collagen Assay
#11BIOMARKERS
#12ANTI-ELASTIN ANTIBODIES AND METHODS OF USE
#13METHODS OF USING SHAPED PARTICLES IN FLOW CYTOMETERS FOR ASSAYS ON B CELLS AND T CELLS
#14BIOMARKERS FOR IDIOPATHIC PULMONARY FIBROSIS AND METHODS OF PRODUCING AND USING SAME
#15Blood Biomarkers and Diagnostic Methods for Small Vessel Diseases
#16SYSTEMS AND METHODS FOR DIAGNOSING AND TREATING CHRONIC ORGAN REJECTION
#17SYSTEMS, APPARATUSES, AND METHODS TO MEASURE ADHESION OF BLOOD CELLS IN MICROFLUIDIC CHANNELS
#18IMMUNOASSAY METHOD FOR CROSS-LINKED N-TELOPEPTIDE OF TYPE I COLLAGEN, IMMUNOASSAY KIT, AND ANTIBODY OR ANTIBODY FRAGMENT THEREOF
#19AFFINITY CAPTURE OF EXTRACELLULAR MATRIX BODIES
#20MONITORING INFLAMMATION STATUS
#21IMMUNOLOGICAL DETECTION METHOD AND IMMUNOLOGICAL DETECTION KIT
#22METHOD FOR DIAGNOSING COLLAGEN DEGRADATION ASSOCIATED DISEASE
#23IMMUNOLOGICAL DETECTION METHOD AND IMMUNOLOGICAL DETECTION KIT
#24PEPTIDE MODULATORS OF THE INTERACTION BETWEEN HUMAN C-PEPTIDE AND HUMAN ELASTIN RECEPTOR FOR THERAPEUTIC USE
#25BIOMARKERS AND THEIR USE IN DIAGNOSING PARKINSON'S DISEASE, VITREORETINAL DISEASES, AND AGE-RELATED PATHOLOGIES
#26Collagen Type XXII Assay
#27Anastellin Biomarker
#28Anastellin Biomarker
#29FUSION PROTEINS AND METHODS FOR MONITORING FIBRONECTIN MATRIX ASSEMBLY
#30COMPOSITIONS AND METHODS FOR DIAGNOSING AND/OR TREATING CHRONIC KIDNEY DISEASE
#31Method for Detecting Cancer in a Patient
#32COLLAGEN TYPE VII ALPHA 1 ASSAY
#33MOLECULAR MARKER FOR DETERMINING VERY-EARLY-STAGE ONSET RISK OF GASTRIC CANCER AND EVALUATING PROGRESSION RISK OF PRE-CANCEROUS LESION OF GASTRIC CANCER, AND USE THEREOF IN DIAGNOSTIC KIT
#34METHOD OF DETECTING PROTEINS IN HUMAN SAMPLES AND USES OF SUCH METHODS
#35BIOMARKER FOR NEURODEGENERATIVE DISEASES COMPRISING GLYCOTOXIN, SPECIFIC PROTEIN BOUND TO GLYCOTOXIN, OR GLYCOTOXIN-SPECIFIC PROTEIN COMPLEX
#36Proteomic Risk Score For Osteoarthritis (OA)
#37CD8A-Binding Fibronectin Type III Domains
#38USE OF FIBRONECTIN IN PREDICTING PREECLAMPSIA
#39Renal Insufficiency Prediction and Uses Thereof
#40CARTILAGE MODEL AS A SUBSTITUTE FOR ANIMAL MODELS AND METHODS FOR EVALUATING EFFECTIVENESS OR TOXICITY OF DRUGS USING THE SAME
#41PROTEOMIC SAMPLE INVESTIGATION METHOD FOR DIAGNOSING RHABDOMYOLYSIS AND KITS FOR IMPLEMENTING SAME
#42PRETREATMENT METHOD FOR QUANTITATIVE DETECTION OF UNDENATURED TYPE II COLLAGEN IN COLLAGEN PRODUCT OR CARTILAGE, AND APPLICATION
#43Type XIX Collagen Assay
#44Immunoassay for Detecting Eosinophilic Esophagitis
#45Serum Albumin-Binding Fibronectin Type III Domains
#46ALK FUSION GENES AND USES THEREOF
#47Assay for Detecting Collagen XI Biomarkers
#48Addressable Microfluidics Systems and Methods for In Vivo Applications
#49METHOD OF ASSISTING BREAST CANCER DIAGNOSIS AND TEST KIT FOR BREAST CANCER
#50METHODS OF ASSESSING RISK OF AND TREATING PREECLAMPSIA AND SUBTYPES THEREOF
#51Biomarker of Fibrosis
#52MODIFIED FIBROBLAST GROWTH FACTOR 21 (FGF-21) FOR USE IN METHODS FOR TREATING NONALCOHOLIC STEATOHEPATITIS (NASH)
#53COMBINATION OF BIOMARKERS OF PRETERM DELIVERY
#54Methods for Using Collagen Hybridizing Peptides to Determine Collagen Content
#55Assay for Assessing Cancer
#56Collagen Type XVIII Assay
#57METHOD FOR MEASURING FRAGMENTS CONTAINING HUMAN TYPE IV COLLAGEN 7S DOMAIN AND KIT FOR USE THEREIN
#58MATURATION SUPPRESSOR AND MATURATION SUPPRESSION METHOD FOR DENDRITIC CELLS, AND PHARMACEUTICAL COMPOSITION
#59METHOD OF DIAGNOSING BREAST CANCER
#60Assay for Assessing Heart Failure
#61METABOLIC BIOMARKERS FOR PREDICTING RESPONSIVENESS TO FGF-18 COMPOUND
#62BONE TURNOVER MARKERS ADJUSTMENT
#63SYSTEMS AND METHODS FOR DETECTION OF LAMININ BETA-1 SUBUNIT WITHIN TISSUE
#64USE OF TENASCIN-C AS AN EXTRACELLULAR MARKER OF TUMOR-DERIVED MICROPARTICLES
#65CD8A-binding fibronectin type III domains
#66Probe for Specifically Detecting Pathological Collagens, and Preparation Method Therefor and Use Thereof
#67Blood biomarkers and diagnostic methods for small vessel diseases
#68BIOMARKERS FOR DIAGNOSING BREAST CANCER AND USES THEREOF
#69LATERAL FLOW IMMUNOASSAY DEVICES AND METHODS OF USING SAME
#70IDENTIFICATION OF PATIENTS WITH ABNORMAL FRACTIONAL SHORTENING
#71METHODS FOR DIAGNOSING AND EVALUATING NON-ALCOHOLIC STEATOHEPATITIS
#72BIOMARKERS OF EARLY OSTEOARTHRITIS
#73OVARIAN CANCER BIOMARKER AND METHODS OF USING SAME
#74BIOMARKERS FOR JOINT AILMENTS AND USES THEREOF
#75DETECTION OF DYSTROGLYCAN
#76Microbe-binding molecules and uses thereof
#77Type XXIII Collagen Assay
#78OSTEOMODULIN AND OSTEOMODULIN FRAGMENTS AS BIOMARKERS FOR OSTEOARTHRITIS AND USE THEREOF
#79Immunoassay for Collagen Type VIII Sequences
#80METHODS OF DETECTING SEPTIC ARTHRITIS, TRANSIENT SYNOVITIS AND OSTEOMYELITIS
#81Collagen Type X Alpha-1 Assay
#82IDENTIFICATION AND TARGETING OF PATHOGENIC EXTRACELLULAR MATRIX FOR DIAGNOSIS AND TREATMENT OF CANCER AND OTHER DISEASES
#83ANTI-ELASTIN ANTIBODIES AND METHODS OF USE
#84METHODS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF NEUROLOGICAL DISORDERS AND DISEASES USING FNDC5
#85DIMERIC COLLAGEN HYBRIDIZING PEPTIDES AND METHODS OF USE THEREOF
#86MARKERS USEFUL IN ENRICHMENT STRATEGIES FOR THE TREATMENT OF OSTEOARTHRITIS
#87SELECTIVE GLUCOCORTICOID RECEPTOR MODIFIERS FOR TREATING IMPAIRED SKIN WOUND HEALING
#88PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING FABRY DISEASE, CONTAINING TSP1 PROTEIN INHIBITOR AS ACTIVE INGREDIENT
#89PD-L1 binding polypeptides for imaging
#90Dimeric collagen hybridizing peptides and methods of using
#91Method for detecting an increased risk or incidence of colorectal cancer
#92COLLAGEN TYPE VII ALPHA 1 ASSAY
#93Metabolic biomarkers for predicting responsiveness to FGF-18 compound
#94Serum albumin-binding fibronectin type III domains
#95METHOD AND KIT FOR THE DIAGNOSIS OF COLORECTAL CANCER
#96METHOD FOR DIAGNOSING LIVER DISEASES AND METHOD FOR SCREENING THERAPEUTIC AGENT FOR LIVER DISEASES USING CHANGES IN EXPRESSION OF TM4SF5 PROTEIN
#97Classification of periodontitis patients
#98COLLAGEN IV BINDING ASSAY FOR THE DETECTION OF COLLAGEN VII
#99BIOMARKERS AND USES THEREOF
#100Detection of autoantibodies for diagnosing degenerative diseases of the skeletal system
#101Modified fibroblast growth factor 21 (FGF-21) for use in methods for treating nonalcoholic steatohepatitis (NASH)
#102MEANS AND METHODS FOR MONITORING SCAR DEVELOPMENT
#103Lateral flow immunoassay strip device
#104CD8A-binding fibronectin type III domains
#105GINGIVITIS DIAGNOSTIC METHODS, USES AND KITS
#106Elastin Assay
#107METHOD AND APPARATUS FOR ADMINISTERING GASES INCLUDING NITRIC OXIDE
#108Collagen Type XVI Assay
#109Systems and methods for diagnosing and treating chronic organ rejection
#110Tumstatin Assay
#111LATERAL FLOW IMMUNOASSAY DEVICES AND METHODS OF USING SAME
#112Biomarkers for joint ailments and uses thereof
#113RAPID TEST FOR CELLULAR FIBRONECTIN
#114Microbe-binding molecules and uses thereof
#115Biomarkers for risk assessment and treatment monitoring in heart failure patients guided by natriuretic peptides
#116Devices and methods related to airway inflammation
#117BIOLOGICAL MATERIALS AND THERAPEUTIC USES THEREOF
#118METHOD FOR ESTIMATING THE EFFECTIVENESS AGAINST RHEUMATOID ARTHRITIS OF A T-LYMPHOCYTE CO-STIMULATION MODULATOR AGENT
#119Methods for detecting sinusoidal obstructive syndrome (SOS)
#120Method for prediction of response to cardiovascular regeneration based on detecting the amount of biomarkers
#121Collagen Type X Alpha-1 Assay
#122Collagen type X alpha-1 assay
#123Methods for the treatment of neurological disorders and diseases using FNDC5
#124BLOOD BIOMARKERS AND DIAGNOSTIC METHODS FOR SMALL VESSEL DISEASES
#125Peptides and compositions for treatment of joint damage
#126Microbe-binding molecules and uses thereof
#127PD-L1 binding polypeptides for imaging
#128Immunoassay for collagen type VI
#129Targeting peptides and methods of use
#130Nidogen-1 Fragments Assay
#131Methods of diagnosing hepatocellular carcinoma and pancreatic cancer
#132Human antibody against ED-B domain of fibronectin and uses thereof
#133Method for detecting an increased risk or incidence of colorectal cancer
#134Peptides and compositions for treatment of joint damage
#135Marker for Prognosis of a Clinical Outcome of an Autologous Intervertebral Disc Cell Transplantation, for Progress Assessment/Progress Monitoring of an Autologous Intervertebral Disc Cell Transplantation, for Assessing the Quality of Intervertebral Disc Cells, for Assessing the Quality of an Implant and/or Medication for Novel Therapies (ATMP) for the Treatment of an Intervertebral Disc Defect, and for Diagnosis of an Intervertebral and/or Spinal Column Defect
#136SYSTEMS AND METHODS FOR EVALUATING INTERSTITIAL FLUIDS
#137Vagus nerve stimulation to treat neurodegenerative disorders
#138Method of diagnosing arthritis or other joint degrading disease
#139ONCOFETAL FIBRONECTIN DETECTION METHOD USING SIMPLE IMMUNOASSAY
#140Method for producing animal model of preterm birth and animal model of preterm birth produced by the method
#141METHOD FOR DETECTING ONCOFETAL FIBRONECTIN USING IMMUNOCHROMATOGRAPHY
#142COMPOSITIONS AND METHODS THAT INVOLVE PROTEIN SCAFFOLDS THAT SPECIFICALLY BIND TO HEPATOCYTE GROWTH FACTOR RECEPTOR
#143Method and kit for the diagnosis of colorectal cancer
#144Osteomodulin and osteomodulin fragments as biomarkers for osteoarthritis and use thereof
#145DUAL ANTI-PLATELET MEDICATION/ASPIRIN RESPONSE AND REACTIVITY TEST USING SYNTHETIC COLLAGEN
#146Anti-laminin4 antibodies specific for LG4-5
#147Microbe-binding molecules and uses thereof
#148PEPTIDES WITH ANTI-ANGIOGENIC, ANTI-LYMPHANGIOGENIC, AND ANTI-EDEMIC PROPERTIES AND NANOPARTICLE FORMULATIONS
#149Methods to Diagnose, Treat and Prevent Bone Loss
#150PEPTIDE AND BIOMARKER ASSOCIATED WITH INFLAMMATORY DISORDERS, AND USES THEREOF
#151ANTI-PLATELET RESPONSE AND REACTIVITY TEST USING SYNTHETIC COLLAGEN
#152METHOD FOR EVALUATING ARTICULAR JOINT THERAPEUTICS
#153Biochemical Markers for Pulmonary and Other Diseases
#154Methods for diagnosing and evaluating non-alcoholic steatohepatitis
#155METHOD AND KIT FOR DIAGNOSING EPITHELIAL-TO-MESENCHYMAL TRANSITION (EMT) OF THE PERITONEUM
#156Immunoassay for Collagen Type VIII Sequences
#157BIOMARKER FOR DIAGNOSIS OF NEUROMYELITIS OPTICA OR MULTIPLE SCLEROSIS AND USE THEREOF
#158METHODS FOR DETERMINING THE RISK OF A SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENT TO DEVELOP NEUROPSYCHIATRIC SYNDROMES
#159Anti-Laminin4 antibodies specific for LG4-5
#160Assessing whether a subject shall be subjected to imaging based diagnostic
#161Methods for determining prognosis of colorectal cancer
#162Peptides and compositions for treatment of joint damage
#163Characterization of Type 1 Collagen Synthesis By Fluorescence Imaging and Related Drug Screening Technique
#164DUAL ANTI-PLATELET MEDICATION/ASPIRIN RESPONSE AND REACTIVITY TEST USING SYNTHETIC COLLAGEN
#165CD8a-binding fibronectin type III domains
#166Fibronectin type III repeat based protein scaffolds with alternative binding surfaces
#167FIBRONECTIN-BASED BINDING MOLECULES AND USES THEREOF
#168CELL ANALYSIS USING DYNAMIC BIOPHYSICAL METHODS
#169AZO-quaternary pyridinium salts with acid-enhanced antibacterial efficacy, methods of use, methods of synthesis, and uses thereof
#170Methods to Diagnose, Treat and Prevent Bone Loss
#171Immunoassay for Collagen Type VI Sequence
#172Electrochemical aptasensors with a gelatin B matrix
#173Collagen IV binding assay for the detection of collagen VII
#174Compositions, methods and kits for diagnosis of lung cancer
#175Dimeric collagen hybridizing peptides and methods of using
#176Device and associated methods for performing luminescence and fluorescence measurements of a sample
#177Device and associated methods for performing luminescence and fluorescence measurements of a sample
#178COMPOSITIONS AND METHODS FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ASTHMA
#179Non-invasive method for assessing liver fibrosis progression
#180Anti-Angiogenic Properties of Collagen V Derived Fragments
#181Peptides and compositions for treatment of joint damage
#182Method for evaluating articular joint therapeutics
#183COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER
#184Identity and purity of tissue biopsies
#185PD-L1 binding polypeptides for imaging
#186Multivalent fibronectin-integrin binding compositions and methods of use thereof
#187Targeting peptides and methods of use
#188Automated immunoanalyzer system for performing diagnostic assays for allergies and autoimmune diseases
#189Automated immunoanalyzer system for performing diagnostic assays for autoimmune and infectious diseases
#190Automated immunoanalyzer system for performing diagnostic assays for autoimmune and infectious diseases
#191METHODS FOR DIAGNOSIS AND PROGNOSIS OF CANCER
#192Fibrosis biomarker assay
#193METHODS AND COMPOSITIONS FOR IMAGING VIA MOLECULAR BIASING
#194Markers of the male urogenital tract
#195Methods and compositions for wound treatment
#196METHODS OF DIAGNOSING HEPATOCELLULAR CARCINOMA AND PANCREATIC CANCER
#197Microchip for assay of blood properties, and device for assay of blood properties
#198Biomarkers associated with schizophrenia
#199Method for detecting an increased risk or incidence of colorectal cancer
#200Electrochemical aptasensors with a gelatin B matrix
#201FIBRONECTIN-BASED BINDING MOLECULES AND USES THEREOF
#202Peptides and compositions for treatment of joint damage
#203Collagens as markers for breast cancer treatment
#204Method for obtaining thin fibril collagen by contacting native collagen with an antibody
#205Methods and monitoring of treatment with a WNT pathway inhibitor
#206Magnetic apparatus and methods of use
#207Biomarkers for risk assessment and treatment monitoring in heart failure patients guided by natriuretic peptides
#208Biochemical markers for pulmonary and other diseases
#209Methods to Diagnose Treat and Prevent Bone Loss
#210System and method for studying matrix vesicle calcification
#211METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF SEPSIS
#212METHODS AND PRODUCTS FOR THE DIAGNOSIS AND PROGNOSIS OF OVARIAN TUMOR MALIGNANCY
#213Frequency domain discrimination of tissue proteins
#214Peptides and compositions for treatment of joint damage
#215Novel Skin Remodeling Strategy
#216Cell analysis using dynamic biophysical methods
#217Combined biomarker measurement of fibrosis
#218Methods for the treatment of neurological disorders and diseases using FNDC5
#219Devices and methods related to airway inflammation
#220Gene and protein expression properties of adherent stromal cells cultured in 3D
#221STROMA BIOMARKERS FOR THE DIAGNOSIS OF PROSTATE CANCER
#222Collagen Type X Alpha-1 Assay
#223METHODS FOR ASSAYING JAK2 ACTIVITY IN RED BLOOD CELLS AND USES THEREOF
#224METHODS FOR ANALYZING ELASTIC FIBER INJURY MARKERS AND DIAGNOSIS OF DISEASES ASSOCIATED WITH ELASTIC FIBER INJURY
#225Fibrosis biomarker assay
#226CHONDROADHERIN FRAGMENTS AS INDICATORS OF INTERVERTEBRAL DISC DEGENERATION
#227Collagen Type VI Alpha-1 Assay
#228PIIINP neo-epitope assay
#229Fibronectin type III repeat based protein scaffolds with alternative binding surfaces
#230Composition, device, and method for biological air sampling
#231Collagen IV binding assay for the detection of collagen VII
#232Methods for determining prognosis of colorectal cancer
#233MOLECULAR TARGETS AND COMPOUNDS, AND METHODS TO IDENTIFY THE SAME, USEFUL IN THE TREATMENT OF DISEASES ASSOCIATED WITH EPITHELIAL MESENCHYMAL TRANSITION
#234BLUE COLLAGENASE ASSAY
#235METHOD T0 MAKE AN AQUEOUS POUR POINT DEPRESSANT DISPERSION COMPOSITION
#236METHODS AND PRODUCTS FOR PROGNOSING THE CLINICAL EVOLUTION, OR PREDICTING THE RECURRENCE RISK, OF A PAPILLARY LESION OF THE BREAST
#237RAPID TEST FOR CELLULAR FIBRONECTIN
#238Methods and products for in vitro diagnosis, in vitro prognosis and the development of drugs against invasive carcinomas
#239Cell culture models for validating candidate compounds for use in treating COPD and other diseases
#240Method and system for assessing fibrosis in a tissue
#241Method for detecting neurological disease accompanied by inflammation and/or demyelination
#242EPITHELIAL OVARIAN CANCER DIFFERENTIATION MARKER
#243Collagen-derived recombinant proteins with von Willebrand factor-binding activity
#244Anti-Laminin4 antibodies specific for LG4-5
#245Isolated cardiac stem cells and methods of their use
#246Generation of airway and lung progenitors and epithelial cells and three-dimensional anterior foregut spheres
#247Automated immunoanalyzer system for performing diagnostic assays for autoimmune and infectious diseases
#248Automated immunoanalyzer system for performing diagnostic assays for autoimmune and infectious diseases
#249IDENTIFICATION OF PATIENTS WITH ABNORMAL FRACTIONAL SHORTENING
#250Device and associated methods for performing luminescence and fluorescence measurements of a sample
#251Device and associated methods for performing luminescence and fluorescence measurements of a sample
#252Methods of predicting and decreasing the risk of pre-term birth
#253Renal Cell Carcinoma Biomarkers and Uses Thereof
#254Detection of diagnostic peptides
#255COMPOSITIONS COMPRISING MODIFIED COLLAGEN AND USES THEREFOR
#256Methods for detecting oncofetal fibronectin
#257Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof
#258Maternal biomarkers for gestational diabetes
#259Compositions, methods and kits for diagnosis of lung cancer
#260Multiple biomarker set for breast cancer diagnosis, method of detecting the same, and diagnosis kit for breast cancer using antibody against the same
#261EXTRACELLULAR AND MEMBRANE-ASSOCIATED PROSTATE CANCER MARKERS
#262Theranostics platform and methods of use
#263Method of determining the viability of at least one cell
#264Methods of predicting and decreasing the risk of pregnancy loss
#265Method of screening drugs that promote LOXL1 expression
#266Automated immunoanalyzer system for performing diagnostic assays for allergies and autoimmune diseases
#267Method for treating osteoporosis
#268Biomarker for replicative senescence
#269In vitro assay method using immunological technique
#270Undercarboxylated/uncarboxylated osteocalcin increases beta-cell proliferation, insulin secretion, insulin sensitivity, glucose tolerance and decreases fat mass
#271Hybridoma cell line for producing antibody for type II collagen
#272Method for evaluating regenerated cartilage
#273ELISA ASSAY KIT, ELISA FOR DETERMINING DESMOSINE LEVELS FROM URINE SAMPLES AND DIAGNOSTIC URINE ASSAYS FOR ANEURYSMS
#274Composition, device, and method for biological air sampling
#275Markers of the male urogenital tract
#276Methods of determining chondrocytes
#277Methods for detecting oncofetal fibronectin
#278Specific binding sites in collagen for integrins and use thereof
#279Compositions comprising modified collagen and uses therefor
#280Fibronectin type III repeat based protein scaffolds with alternative binding surfaces
#281Fibronectin aggrecan biomarker for the identification of spinal and joint source of pain
#282COLORECTAL CANCER MARKER VITRONECTIN AND METHOD FOR ANALYZING VITRONECTIN CONCENTRATION IN BLOOD SAMPLE
#283Renal Cell Carcinoma Biomarkers and Uses Thereof
#284METHODS OF PREDICTING AND DECREASING THE RISK OF PREGNANCY LOSS
#285BIOMARKERS BASED ON A MULTI-CANCER INVASION-ASSOCIATED MECHANISM
#286METHOD OF IN-VITRO IMMUNOASSAY
#287Extracellular and membrane-associated prostate cancer markers
#288Lysyl oxidase-like 1 (LOXL1) and elastogenesis
#289Determination of Exosomel Biomarkers for Predicting Cardiovascular Events
#290Method for Treating Arteriosclerosis
#291Method for producing recombinant antibody and antibody fragment thereof
#292METHOD OF PREDICTING RISK OF PRE-TERM BIRTH
#293MELANOMA PROGNOSTIC MODEL USING TISSUE MICROARRAYS AND GENETIC ALGORITHMS
#294COLLAGEN NEOEPITOPE ANTIBODY
#295Blood Biomarkers for Bone Fracture and Cartilage Injury
#296SPECIFIC BINDING SITES IN COLLAGEN FOR INTEGRINS AND USE THEREOF
#297Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
#298METHOED FOR DETECTING CIRCULATING CARTILAGE OLIGOMERIC MATRIX PROTEIN IN THE DIAGNOSIS AND MONITORING OF CIRRHOSIS
#299Profiling fragments of elastic fibers and microfibrils as biomarkers for disease
#300SERUM BIOMARKERS FOR CHAGAS DISEASE